Headline:
Italian Health Authority Warns of Severe Side Effects from Metamizole-Containing Drugs
Article:
The Italian Medicines Agency (AIFA) has issued a warning regarding drugs containing the active ingredient metamizole, which could potentially cause severe reactions such as agranulocytosis. This includes common over-the-counter medicines like Novalgina and its generics, used for their analgesic and antipyretic properties.
Agranulocytosis is a condition that reduces the level of a type of white blood cell called granulocytes, crucial for fighting bacterial and fungal infections. Low levels can leave the body vulnerable, sometimes presenting symptoms akin to the flu, such as fever, sore throat, and chills.
AIFA recommends immediate medical consultation if you’re undergoing metamizole therapy. Professor Pierluigi Navarra, speaking to Il Fatto Quotidiano, noted that metamizole belongs to a drug class that has been phased out in many countries. "It was also administered as drops, believed to be less harsh on the gastric mucosa," he said.
Professor Navarra further explained that while metamizole consumption has decreased over time due to reported side effects, it’s essential for doctors to be aware of the potential adverse reaction. "If a patient shows signs of infection, the doctor might attribute it to the metamizole," he added.
Alternatives to metamizole, such as ibuprofen, are available and do not carry the same risks. It’s crucial to consult your doctor and be aware of the drugs you’re taking to avoid unpleasant surprises.
Sources: AIFA, Il Fatto Quotidiano
